COMMUNIQUÉS West-GlobeNewswire

Globus Medical Schedules Second Quarter Earnings Release and Conference Call
16/07/2024
AUDUBON, Pa., July 16, 2024 (GLOBE NEWSWIRE) -- Globus Medical , Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the second quarter ended June 30, 2024 after the [...]
FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements
16/07/2024
Reaffirms commitment to regaining compliance with the NYSE American continued listing standards MINNEAPOLIS, MN, July 16, 2024 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the “Company” or “FOXO”), [...]
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
16/07/2024
BRISBANE, Calif., July 16, 2024 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing novel therapies for neuroinflammatory diseases of the body, brain, and eye, today announced that it [...]
Inari Medical to Announce Second Quarter 2024 Financial Results
16/07/2024
IRVINE, Calif., July 16, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other [...]
Surgery Partners, Inc. Announces Second Quarter 2024 Earnings Release Date and Conference Call Details
16/07/2024
BRENTWOOD, Tenn., July 16, 2024 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will [...]
Beyond Air® To Participate in the BTIG Virtual Biotechnology Conference 2024
16/07/2024
GARDEN CITY, N.Y., July 16, 2024 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”) a commercial stage medical device and biopharmaceutical company focused on harnessing the power of [...]
Aeterna Zentaris Announces Results of Virtual 2024 Meeting of Shareholders
16/07/2024
TORONTO, ONTARIO, July 16, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) ("Aeterna" or the "Company"), a specialty biopharmaceutical company developing and commercializing a diversified [...]
Aclaris Therapeutics Announces Sale of OLUMIANT® Royalties and Milestones to OMERS Life Sciences for Up to $31.5 Million
16/07/2024
- Non-Dilutive Transaction Strengthens Balance Sheet to Support Strategic Priorities - - $26.5 Million Upfront Plus Up to $5.0 Million Milestone - WAYNE, Pa., July 16, 2024 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc [...]
C4 Therapeutics to Present Preliminary Monotherapy Data from the Ongoing Phase 1 Trial of CFT1946 as a Mini Oral Presentation at the ESMO Congress 2024
16/07/2024
WATERTOWN, Mass., July 16, 2024 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced [...]
Kiniksa Pharmaceuticals to Report Second Quarter 2024 Financial Results on July 23, 2024
16/07/2024
LONDON, July 16, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, July 23, 2024 at 8:30 a.m. Eastern [...]
TeamHealth launches Post-Acute Care Medical Director Leadership Academy
16/07/2024
KNOXVILLE, Tenn., July 16, 2024 (GLOBE NEWSWIRE) -- TeamHealth is excited to announce the launch of the Post-Acute Care Medical Director Leadership Academy (MDLA), a groundbreaking program aimed at empowering medical [...]
Faraday Pharmaceuticals to Host KOL Webinar on the Unmet Need in the Prevention of Ischemia-Reperfusion Injury in Acute STEMI
16/07/2024
SEATTLE, July 16, 2024 (GLOBE NEWSWIRE) -- Faraday Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on the prevention of heart failure by reducing myocardial damage following acute ST-elevation [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 28 - 2024
16/07/2024
Aggregated presentation by day and by market Purchases of own shares from July 8th to 12th 2024 Name of the Issuer Identity code of the Issuer Day of the transaction Identity code of the financial instrument Total daily [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 28 - 2024
16/07/2024
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 8 au 12 juillet 2024 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction Code [...]
SCCT 2024: HeartFlow to Present New Data on Coronary Artery Disease Management with Coronary Computed Tomography Angiography
16/07/2024
MOUNTAIN VIEW, Calif., July 16, 2024 (GLOBE NEWSWIRE) -- HeartFlow , a leader in non-invasive artificial intelligence (AI) heart care solutions, today announced it will be presenting new findings on the use of coronary [...]
SciSparc Ltd. Announces Receipt of Nasdaq Minimum Bid Price Notification
16/07/2024
TEL AVIV, Israel, July 16, 2024 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders and rare diseases of the [...]
Acentra Health Names Ryan Bosch, MD, as Executive Vice President, Chief Health and Informatics Officer
16/07/2024
Bosch will oversee the company's work to accelerate the delivery of clinically evidenced solutions that improve health outcomes and advance health equity at scale MCLEAN, Va., July 16, 2024 (GLOBE NEWSWIRE) -- Acentra [...]
VIRBAC: exceptional first-half momentum (+16.2% at constant exchange rates) driven by all regions
16/07/2024
KEY FIGURES Revenue in first half of 2024 €703.1M Growth at constant exchange rates and scope 1 +11.3% including companion animals +15.1% farm animals +7.0% Growth at constant exchange rates 2 +16.2% Overall change +15. [...]
VIRBAC; dynamique exceptionnelle sur le premier semestre (+16,2% à taux de change constants) portée par toutes les régions
16/07/2024
CHIFFRES CLÉS Chiffre d’affaires du 1 er semestre 2024 703,1 M€ Croissance à taux de change et périmètre constants 1 +11,3% dont animaux de compagnie +15,1% animaux d’élevage +7,0% Croissance à taux de change constants [...]

Pages